Global Swine Healthcare

Swine Healthcare Comprehensive Study by Application (Livestock, House, Others), Diagnostic Tests (Enzyme Linked Immuno-Sorbent Assay (ELISA), Rapid Immuno Migration (RIM), Agar Gel Immuno-Diffusion (AGID), Polymerase Chain Reaction (PCR), Diagnostic Imaging), Disease (Exudative dermatitis (greasy pig disease), Coccidiosis, Respiratory diseases, Swine dysentery, Porcine parvovirus, Others), Therapeutics (Vaccines, Parasiticide, Anti-infective, Feed additives, Antibiotics, Others) Players and Region - Global Market Outlook to 2030

Swine Healthcare Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Swine Healthcare Market Scope
The increasing demand for livestock products on a global level will drive the growth prospects for the global swine healthcare market during the forecasted period. The adoption rate of antibiotics, vaccines, and other treatments is anticipated to grow with the increasing number of initiatives taken by the government and vendors to prevent any zoonotic disease from affecting livestock production. Since the production of quality livestock products is dependent on the health of the animal, many vendors are increasingly adopting more drugs to prevent and treat diseases of swine. The above two factors will boost the demand for drugs, antibiotics, and vaccines, which, in turn, will propel the rate of revenue generation in the market.

AttributesDetails
Study Period2019-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledZoetis (United States), Merck & Co. Inc. (United States), Boehringer Ingelheim (Georgia), Elanco (Eli Lilly) (United States), Bayer AG (Germany), Novus International (United States), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals PLC (United Kingdom), Norbrook (United Kingdom) and Neogen Corp (United States)
CAGR8.2%


The growing awareness regarding swine health-related products and drugs in the Middle East and Africa about swine health has led to a surge in the growth of the market segment. Countries such as South Africa, Kenya, and Zambia pose a high risk for developing disease outbreaks amongst its swine population, which is expected to result in an increased demand for antibiotics and vaccines. Also, vendors are devising new product development strategies to address the unmet needs in the market. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Swine Healthcare market throughout the predicted period.

Zoetis (United States), Merck & Co. Inc. (United States), Boehringer Ingelheim (Georgia), Elanco (Eli Lilly) (United States), Bayer AG (Germany), Novus International (United States), Virbac (France), Vetoquinol S.A. (France), Dechra Pharmaceuticals PLC (United Kingdom), Norbrook (United Kingdom) and Neogen Corp (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Huvepharma EOOD (Bulgaria), Lillidale Animal Health (United Kingdom) and International Health Care Limited (India).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Swine Healthcare market by Type , by Application (Livestock, House and Others) and Region with country level break-up.

On the basis of geography, the market of Swine Healthcare has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
On 1st August 2019, Elanco Animal Health announced its acquisition of Montreal based Prevtec Microbia Inc. which is a biotechnology startup specializing in the development of vaccines to restrain the bacterial diseases in food animals. Elanco’s partnership with Prevtec proved to be successful resulting in the delivery of non-antibiotic solutions for swine producers.
In May 2022, Boehringer Ingelheim launched TwistPak, a mixing platform for swine vaccines, demonstrating innovation in vaccine administration for swine health.


Influencing Trend:
Increasing Prevalence of Swine Influenza

Market Growth Drivers:
Growing Pig Farming Globally is Increasing the Demand for Swine Healthcare and Increasing Worldwide Consumption of Pig Meat

Challenges:
Stringent Regulatory Norms Regarding Swine Healthcare

Restraints:
High-Cost Maintenance and Storage of Vaccines

Opportunities:
Raising Awareness about Animal Health will Boost Swine Healthcare Market and Research and Innovation in Swine Healthcare Vaccines

Key Target Audience
Swine Healthcare Providers, Research and Development Institutes, Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Application
  • Livestock
  • House
  • Others
By Diagnostic Tests
  • Enzyme Linked Immuno-Sorbent Assay (ELISA)
  • Rapid Immuno Migration (RIM)
  • Agar Gel Immuno-Diffusion (AGID)
  • Polymerase Chain Reaction (PCR)
  • Diagnostic Imaging

By Disease
  • Exudative dermatitis (greasy pig disease)
  • Coccidiosis
  • Respiratory diseases
  • Swine dysentery
  • Porcine parvovirus
  • Others

By Therapeutics
  • Vaccines
  • Parasiticide
  • Anti-infective
  • Feed additives
  • Antibiotics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Pig Farming Globally is Increasing the Demand for Swine Healthcare
      • 3.2.2. Increasing Worldwide Consumption of Pig Meat
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Norms Regarding Swine Healthcare
    • 3.4. Market Trends
      • 3.4.1. Increasing Prevalence of Swine Influenza
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Swine Healthcare, by Application, Diagnostic Tests, Disease, Therapeutics and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Swine Healthcare (Value)
      • 5.2.1. Global Swine Healthcare by: Application (Value)
        • 5.2.1.1. Livestock
        • 5.2.1.2. House
        • 5.2.1.3. Others
      • 5.2.2. Global Swine Healthcare by: Diagnostic Tests (Value)
        • 5.2.2.1. Enzyme Linked Immuno-Sorbent Assay (ELISA)
        • 5.2.2.2. Rapid Immuno Migration (RIM)
        • 5.2.2.3. Agar Gel Immuno-Diffusion (AGID)
        • 5.2.2.4. Polymerase Chain Reaction (PCR)
        • 5.2.2.5. Diagnostic Imaging
      • 5.2.3. Global Swine Healthcare by: Disease (Value)
        • 5.2.3.1. Exudative dermatitis (greasy pig disease)
        • 5.2.3.2. Coccidiosis
        • 5.2.3.3. Respiratory diseases
        • 5.2.3.4. Swine dysentery
        • 5.2.3.5. Porcine parvovirus
        • 5.2.3.6. Others
      • 5.2.4. Global Swine Healthcare by: Therapeutics (Value)
        • 5.2.4.1. Vaccines
        • 5.2.4.2. Parasiticide
        • 5.2.4.3. Anti-infective
        • 5.2.4.4. Feed additives
        • 5.2.4.5. Antibiotics
        • 5.2.4.6. Others
      • 5.2.5. Global Swine Healthcare Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Swine Healthcare: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co. Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boehringer Ingelheim (Georgia)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco (Eli Lilly) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bayer AG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Novus International (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Virbac (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vetoquinol S.A. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Dechra Pharmaceuticals PLC (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Norbrook (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Neogen Corp (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Swine Healthcare Sale, by Application, Diagnostic Tests, Disease, Therapeutics and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Swine Healthcare (Value)
      • 7.2.1. Global Swine Healthcare by: Application (Value)
        • 7.2.1.1. Livestock
        • 7.2.1.2. House
        • 7.2.1.3. Others
      • 7.2.2. Global Swine Healthcare by: Diagnostic Tests (Value)
        • 7.2.2.1. Enzyme Linked Immuno-Sorbent Assay (ELISA)
        • 7.2.2.2. Rapid Immuno Migration (RIM)
        • 7.2.2.3. Agar Gel Immuno-Diffusion (AGID)
        • 7.2.2.4. Polymerase Chain Reaction (PCR)
        • 7.2.2.5. Diagnostic Imaging
      • 7.2.3. Global Swine Healthcare by: Disease (Value)
        • 7.2.3.1. Exudative dermatitis (greasy pig disease)
        • 7.2.3.2. Coccidiosis
        • 7.2.3.3. Respiratory diseases
        • 7.2.3.4. Swine dysentery
        • 7.2.3.5. Porcine parvovirus
        • 7.2.3.6. Others
      • 7.2.4. Global Swine Healthcare by: Therapeutics (Value)
        • 7.2.4.1. Vaccines
        • 7.2.4.2. Parasiticide
        • 7.2.4.3. Anti-infective
        • 7.2.4.4. Feed additives
        • 7.2.4.5. Antibiotics
        • 7.2.4.6. Others
      • 7.2.5. Global Swine Healthcare Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Swine Healthcare: by Application(USD Million)
  • Table 2. Swine Healthcare Livestock , by Region USD Million (2018-2023)
  • Table 3. Swine Healthcare House , by Region USD Million (2018-2023)
  • Table 4. Swine Healthcare Others , by Region USD Million (2018-2023)
  • Table 5. Swine Healthcare: by Diagnostic Tests(USD Million)
  • Table 6. Swine Healthcare Enzyme Linked Immuno-Sorbent Assay (ELISA) , by Region USD Million (2018-2023)
  • Table 7. Swine Healthcare Rapid Immuno Migration (RIM) , by Region USD Million (2018-2023)
  • Table 8. Swine Healthcare Agar Gel Immuno-Diffusion (AGID) , by Region USD Million (2018-2023)
  • Table 9. Swine Healthcare Polymerase Chain Reaction (PCR) , by Region USD Million (2018-2023)
  • Table 10. Swine Healthcare Diagnostic Imaging , by Region USD Million (2018-2023)
  • Table 11. Swine Healthcare: by Disease(USD Million)
  • Table 12. Swine Healthcare Exudative dermatitis (greasy pig disease) , by Region USD Million (2018-2023)
  • Table 13. Swine Healthcare Coccidiosis , by Region USD Million (2018-2023)
  • Table 14. Swine Healthcare Respiratory diseases , by Region USD Million (2018-2023)
  • Table 15. Swine Healthcare Swine dysentery , by Region USD Million (2018-2023)
  • Table 16. Swine Healthcare Porcine parvovirus , by Region USD Million (2018-2023)
  • Table 17. Swine Healthcare Others , by Region USD Million (2018-2023)
  • Table 18. Swine Healthcare: by Therapeutics(USD Million)
  • Table 19. Swine Healthcare Vaccines , by Region USD Million (2018-2023)
  • Table 20. Swine Healthcare Parasiticide , by Region USD Million (2018-2023)
  • Table 21. Swine Healthcare Anti-infective , by Region USD Million (2018-2023)
  • Table 22. Swine Healthcare Feed additives , by Region USD Million (2018-2023)
  • Table 23. Swine Healthcare Antibiotics , by Region USD Million (2018-2023)
  • Table 24. Swine Healthcare Others , by Region USD Million (2018-2023)
  • Table 25. South America Swine Healthcare, by Country USD Million (2018-2023)
  • Table 26. South America Swine Healthcare, by Application USD Million (2018-2023)
  • Table 27. South America Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 28. South America Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 29. South America Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 30. Brazil Swine Healthcare, by Application USD Million (2018-2023)
  • Table 31. Brazil Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 32. Brazil Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 33. Brazil Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 34. Argentina Swine Healthcare, by Application USD Million (2018-2023)
  • Table 35. Argentina Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 36. Argentina Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 37. Argentina Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 38. Rest of South America Swine Healthcare, by Application USD Million (2018-2023)
  • Table 39. Rest of South America Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 40. Rest of South America Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 41. Rest of South America Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 42. Asia Pacific Swine Healthcare, by Country USD Million (2018-2023)
  • Table 43. Asia Pacific Swine Healthcare, by Application USD Million (2018-2023)
  • Table 44. Asia Pacific Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 45. Asia Pacific Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 46. Asia Pacific Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 47. China Swine Healthcare, by Application USD Million (2018-2023)
  • Table 48. China Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 49. China Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 50. China Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 51. Japan Swine Healthcare, by Application USD Million (2018-2023)
  • Table 52. Japan Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 53. Japan Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 54. Japan Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 55. India Swine Healthcare, by Application USD Million (2018-2023)
  • Table 56. India Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 57. India Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 58. India Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 59. South Korea Swine Healthcare, by Application USD Million (2018-2023)
  • Table 60. South Korea Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 61. South Korea Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 62. South Korea Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 63. Taiwan Swine Healthcare, by Application USD Million (2018-2023)
  • Table 64. Taiwan Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 65. Taiwan Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 66. Taiwan Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 67. Australia Swine Healthcare, by Application USD Million (2018-2023)
  • Table 68. Australia Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 69. Australia Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 70. Australia Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Swine Healthcare, by Application USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 75. Europe Swine Healthcare, by Country USD Million (2018-2023)
  • Table 76. Europe Swine Healthcare, by Application USD Million (2018-2023)
  • Table 77. Europe Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 78. Europe Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 79. Europe Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 80. Germany Swine Healthcare, by Application USD Million (2018-2023)
  • Table 81. Germany Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 82. Germany Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 83. Germany Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 84. France Swine Healthcare, by Application USD Million (2018-2023)
  • Table 85. France Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 86. France Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 87. France Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 88. Italy Swine Healthcare, by Application USD Million (2018-2023)
  • Table 89. Italy Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 90. Italy Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 91. Italy Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 92. United Kingdom Swine Healthcare, by Application USD Million (2018-2023)
  • Table 93. United Kingdom Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 94. United Kingdom Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 95. United Kingdom Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 96. Netherlands Swine Healthcare, by Application USD Million (2018-2023)
  • Table 97. Netherlands Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 98. Netherlands Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 99. Netherlands Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 100. Rest of Europe Swine Healthcare, by Application USD Million (2018-2023)
  • Table 101. Rest of Europe Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 102. Rest of Europe Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 103. Rest of Europe Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 104. MEA Swine Healthcare, by Country USD Million (2018-2023)
  • Table 105. MEA Swine Healthcare, by Application USD Million (2018-2023)
  • Table 106. MEA Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 107. MEA Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 108. MEA Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 109. Middle East Swine Healthcare, by Application USD Million (2018-2023)
  • Table 110. Middle East Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 111. Middle East Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 112. Middle East Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 113. Africa Swine Healthcare, by Application USD Million (2018-2023)
  • Table 114. Africa Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 115. Africa Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 116. Africa Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 117. North America Swine Healthcare, by Country USD Million (2018-2023)
  • Table 118. North America Swine Healthcare, by Application USD Million (2018-2023)
  • Table 119. North America Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 120. North America Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 121. North America Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 122. United States Swine Healthcare, by Application USD Million (2018-2023)
  • Table 123. United States Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 124. United States Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 125. United States Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 126. Canada Swine Healthcare, by Application USD Million (2018-2023)
  • Table 127. Canada Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 128. Canada Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 129. Canada Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 130. Mexico Swine Healthcare, by Application USD Million (2018-2023)
  • Table 131. Mexico Swine Healthcare, by Diagnostic Tests USD Million (2018-2023)
  • Table 132. Mexico Swine Healthcare, by Disease USD Million (2018-2023)
  • Table 133. Mexico Swine Healthcare, by Therapeutics USD Million (2018-2023)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Swine Healthcare: by Application(USD Million)
  • Table 146. Swine Healthcare Livestock , by Region USD Million (2025-2030)
  • Table 147. Swine Healthcare House , by Region USD Million (2025-2030)
  • Table 148. Swine Healthcare Others , by Region USD Million (2025-2030)
  • Table 149. Swine Healthcare: by Diagnostic Tests(USD Million)
  • Table 150. Swine Healthcare Enzyme Linked Immuno-Sorbent Assay (ELISA) , by Region USD Million (2025-2030)
  • Table 151. Swine Healthcare Rapid Immuno Migration (RIM) , by Region USD Million (2025-2030)
  • Table 152. Swine Healthcare Agar Gel Immuno-Diffusion (AGID) , by Region USD Million (2025-2030)
  • Table 153. Swine Healthcare Polymerase Chain Reaction (PCR) , by Region USD Million (2025-2030)
  • Table 154. Swine Healthcare Diagnostic Imaging , by Region USD Million (2025-2030)
  • Table 155. Swine Healthcare: by Disease(USD Million)
  • Table 156. Swine Healthcare Exudative dermatitis (greasy pig disease) , by Region USD Million (2025-2030)
  • Table 157. Swine Healthcare Coccidiosis , by Region USD Million (2025-2030)
  • Table 158. Swine Healthcare Respiratory diseases , by Region USD Million (2025-2030)
  • Table 159. Swine Healthcare Swine dysentery , by Region USD Million (2025-2030)
  • Table 160. Swine Healthcare Porcine parvovirus , by Region USD Million (2025-2030)
  • Table 161. Swine Healthcare Others , by Region USD Million (2025-2030)
  • Table 162. Swine Healthcare: by Therapeutics(USD Million)
  • Table 163. Swine Healthcare Vaccines , by Region USD Million (2025-2030)
  • Table 164. Swine Healthcare Parasiticide , by Region USD Million (2025-2030)
  • Table 165. Swine Healthcare Anti-infective , by Region USD Million (2025-2030)
  • Table 166. Swine Healthcare Feed additives , by Region USD Million (2025-2030)
  • Table 167. Swine Healthcare Antibiotics , by Region USD Million (2025-2030)
  • Table 168. Swine Healthcare Others , by Region USD Million (2025-2030)
  • Table 169. South America Swine Healthcare, by Country USD Million (2025-2030)
  • Table 170. South America Swine Healthcare, by Application USD Million (2025-2030)
  • Table 171. South America Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 172. South America Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 173. South America Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 174. Brazil Swine Healthcare, by Application USD Million (2025-2030)
  • Table 175. Brazil Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 176. Brazil Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 177. Brazil Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 178. Argentina Swine Healthcare, by Application USD Million (2025-2030)
  • Table 179. Argentina Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 180. Argentina Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 181. Argentina Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 182. Rest of South America Swine Healthcare, by Application USD Million (2025-2030)
  • Table 183. Rest of South America Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 184. Rest of South America Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 185. Rest of South America Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 186. Asia Pacific Swine Healthcare, by Country USD Million (2025-2030)
  • Table 187. Asia Pacific Swine Healthcare, by Application USD Million (2025-2030)
  • Table 188. Asia Pacific Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 189. Asia Pacific Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 190. Asia Pacific Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 191. China Swine Healthcare, by Application USD Million (2025-2030)
  • Table 192. China Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 193. China Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 194. China Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 195. Japan Swine Healthcare, by Application USD Million (2025-2030)
  • Table 196. Japan Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 197. Japan Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 198. Japan Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 199. India Swine Healthcare, by Application USD Million (2025-2030)
  • Table 200. India Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 201. India Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 202. India Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 203. South Korea Swine Healthcare, by Application USD Million (2025-2030)
  • Table 204. South Korea Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 205. South Korea Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 206. South Korea Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 207. Taiwan Swine Healthcare, by Application USD Million (2025-2030)
  • Table 208. Taiwan Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 209. Taiwan Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 210. Taiwan Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 211. Australia Swine Healthcare, by Application USD Million (2025-2030)
  • Table 212. Australia Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 213. Australia Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 214. Australia Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 215. Rest of Asia-Pacific Swine Healthcare, by Application USD Million (2025-2030)
  • Table 216. Rest of Asia-Pacific Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 217. Rest of Asia-Pacific Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 218. Rest of Asia-Pacific Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 219. Europe Swine Healthcare, by Country USD Million (2025-2030)
  • Table 220. Europe Swine Healthcare, by Application USD Million (2025-2030)
  • Table 221. Europe Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 222. Europe Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 223. Europe Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 224. Germany Swine Healthcare, by Application USD Million (2025-2030)
  • Table 225. Germany Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 226. Germany Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 227. Germany Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 228. France Swine Healthcare, by Application USD Million (2025-2030)
  • Table 229. France Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 230. France Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 231. France Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 232. Italy Swine Healthcare, by Application USD Million (2025-2030)
  • Table 233. Italy Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 234. Italy Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 235. Italy Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 236. United Kingdom Swine Healthcare, by Application USD Million (2025-2030)
  • Table 237. United Kingdom Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 238. United Kingdom Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 239. United Kingdom Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 240. Netherlands Swine Healthcare, by Application USD Million (2025-2030)
  • Table 241. Netherlands Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 242. Netherlands Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 243. Netherlands Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 244. Rest of Europe Swine Healthcare, by Application USD Million (2025-2030)
  • Table 245. Rest of Europe Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 246. Rest of Europe Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 247. Rest of Europe Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 248. MEA Swine Healthcare, by Country USD Million (2025-2030)
  • Table 249. MEA Swine Healthcare, by Application USD Million (2025-2030)
  • Table 250. MEA Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 251. MEA Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 252. MEA Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 253. Middle East Swine Healthcare, by Application USD Million (2025-2030)
  • Table 254. Middle East Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 255. Middle East Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 256. Middle East Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 257. Africa Swine Healthcare, by Application USD Million (2025-2030)
  • Table 258. Africa Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 259. Africa Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 260. Africa Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 261. North America Swine Healthcare, by Country USD Million (2025-2030)
  • Table 262. North America Swine Healthcare, by Application USD Million (2025-2030)
  • Table 263. North America Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 264. North America Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 265. North America Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 266. United States Swine Healthcare, by Application USD Million (2025-2030)
  • Table 267. United States Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 268. United States Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 269. United States Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 270. Canada Swine Healthcare, by Application USD Million (2025-2030)
  • Table 271. Canada Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 272. Canada Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 273. Canada Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 274. Mexico Swine Healthcare, by Application USD Million (2025-2030)
  • Table 275. Mexico Swine Healthcare, by Diagnostic Tests USD Million (2025-2030)
  • Table 276. Mexico Swine Healthcare, by Disease USD Million (2025-2030)
  • Table 277. Mexico Swine Healthcare, by Therapeutics USD Million (2025-2030)
  • Table 278. Research Programs/Design for This Report
  • Table 279. Key Data Information from Secondary Sources
  • Table 280. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Swine Healthcare: by Application USD Million (2018-2023)
  • Figure 5. Global Swine Healthcare: by Diagnostic Tests USD Million (2018-2023)
  • Figure 6. Global Swine Healthcare: by Disease USD Million (2018-2023)
  • Figure 7. Global Swine Healthcare: by Therapeutics USD Million (2018-2023)
  • Figure 8. South America Swine Healthcare Share (%), by Country
  • Figure 9. Asia Pacific Swine Healthcare Share (%), by Country
  • Figure 10. Europe Swine Healthcare Share (%), by Country
  • Figure 11. MEA Swine Healthcare Share (%), by Country
  • Figure 12. North America Swine Healthcare Share (%), by Country
  • Figure 13. Global Swine Healthcare share by Players 2023 (%)
  • Figure 14. Global Swine Healthcare share by Players (Top 3) 2023(%)
  • Figure 15. Global Swine Healthcare share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 18. Zoetis (United States) Revenue: by Geography 2023
  • Figure 19. Merck & Co. Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck & Co. Inc. (United States) Revenue: by Geography 2023
  • Figure 21. Boehringer Ingelheim (Georgia) Revenue, Net Income and Gross profit
  • Figure 22. Boehringer Ingelheim (Georgia) Revenue: by Geography 2023
  • Figure 23. Elanco (Eli Lilly) (United States) Revenue, Net Income and Gross profit
  • Figure 24. Elanco (Eli Lilly) (United States) Revenue: by Geography 2023
  • Figure 25. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Bayer AG (Germany) Revenue: by Geography 2023
  • Figure 27. Novus International (United States) Revenue, Net Income and Gross profit
  • Figure 28. Novus International (United States) Revenue: by Geography 2023
  • Figure 29. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 30. Virbac (France) Revenue: by Geography 2023
  • Figure 31. Vetoquinol S.A. (France) Revenue, Net Income and Gross profit
  • Figure 32. Vetoquinol S.A. (France) Revenue: by Geography 2023
  • Figure 33. Dechra Pharmaceuticals PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Dechra Pharmaceuticals PLC (United Kingdom) Revenue: by Geography 2023
  • Figure 35. Norbrook (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Norbrook (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Neogen Corp (United States) Revenue, Net Income and Gross profit
  • Figure 38. Neogen Corp (United States) Revenue: by Geography 2023
  • Figure 39. Global Swine Healthcare: by Application USD Million (2025-2030)
  • Figure 40. Global Swine Healthcare: by Diagnostic Tests USD Million (2025-2030)
  • Figure 41. Global Swine Healthcare: by Disease USD Million (2025-2030)
  • Figure 42. Global Swine Healthcare: by Therapeutics USD Million (2025-2030)
  • Figure 43. South America Swine Healthcare Share (%), by Country
  • Figure 44. Asia Pacific Swine Healthcare Share (%), by Country
  • Figure 45. Europe Swine Healthcare Share (%), by Country
  • Figure 46. MEA Swine Healthcare Share (%), by Country
  • Figure 47. North America Swine Healthcare Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Zoetis (United States)
  • Merck & Co. Inc. (United States)
  • Boehringer Ingelheim (Georgia)
  • Elanco (Eli Lilly) (United States)
  • Bayer AG (Germany)
  • Novus International (United States)
  • Virbac (France)
  • Vetoquinol S.A. (France)
  • Dechra Pharmaceuticals PLC (United Kingdom)
  • Norbrook (United Kingdom)
  • Neogen Corp (United States)
Additional players considered in the study are as follows:
Huvepharma EOOD (Bulgaria) , Lillidale Animal Health (United Kingdom) , International Health Care Limited (India)
Select User Access Type

Key Highlights of Report


Apr 2024 227 Pages 79 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Swine Healthcare Quantitative research analysis
Global Swine Healthcare Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Swine Healthcare Market are by end use application [Livestock, House and Others].
The Swine Healthcare Market is gaining popularity and expected to see strong valuation by 2030.
  • Growing Pig Farming Globally is Increasing the Demand for Swine Healthcare
  • Increasing Worldwide Consumption of Pig Meat

Know More About Global Swine Healthcare Report?

Have a Query? Click Here

Other Related Reports

Surgical Navigation Systems Comprehensive Study by Type (Optical Surgical Navigation Systems, Electromagnetic Surgical Navigation Systems, Others), Application (Neurosurgery Surgery , Spinal Surgery,...
$ 3650
Vitamin B12 Comprehensive Study by Application (Food Industry, Nutraceuticals, Pharmaceutical, Dietary Supplements, Others), Form (Syrups, Injection, Tablets, Powder, Nasal Spray, Others), Distributi...
$ 3800
Biomaterial Implants Comprehensive Study by Type (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders, Drug-Delivery Systems)...
$ 3650
Critical Care Services Comprehensive Study by Application (Intensive Care Units, Neonatal Intensive Care Units, Pediatric Intensive Care Units, Coronary Care Units), Critical care equipment (Ventilat...
$ 3750
Bioanalytical Testing Services Comprehensive Study by Type (Cell Based Assays (Bacterial, Viral), Virology Testing (In-Vitro Assays, In-Vivo Assays, Species-Specific Viral PCR Assays), Serology, Immu...
$ 3750
Cerebrospinal Fluid Management Comprehensive Study by Application (Meningitis, Encephalitis, Neurosyphilis, Subarachnoid haemorrhage, Multiple sclerosis, Guillain-Barré syndrome, Meningeal carcinoma...
$ 3750